Ontology highlight
ABSTRACT: Background
Cholinergic dysfunction is increasingly assumed to be involved in the pathophysiology of schizophrenia. Short-latency afferent inhibition (SAI) is a transcranial magnetic stimulation (TMS) paradigm that has been shown to assay central cholinergic activity from the motor cortex (M1). Recently, we established a method to index SAI from the dorsolateral prefrontal cortex (DLPFC), an area implicated in the pathophysiology of schizophrenia. We investigated SAI in M1 and DLPFC in schizophrenia. We hypothesized that modulation of N100 on TMS-evoked potentials (TEPs) from the DLPFC would be attenuated in patients with schizophrenia compared to healthy controls.Methods
SAI was examined in 12 patients, whose age was matched to controls, using TMS combined with electroencep
SUBMITTER: Noda Y
PROVIDER: S-EPMC5768054 | biostudies-literature | 2018 Jan
REPOSITORIES: biostudies-literature